Exploring the global landscape of genetic variation in coagulation factor XI deficiency

Rosanna Asselta, Elvezia Maria Paraboschi, Valeria Rimoldi, Marzia Menegatti, Flora Peyvandi, Ophira Salomon, Stefano Duga

Research output: Contribution to journalArticle

Abstract

Factor XI (FXI) deficiency is an autosomal bleeding disorder, usually posttrauma or postsurgery, characterized by reduced levels of coagulation FXI in plasma. The disease is highly prevalent in Ashkenazi Jews (heterozygote frequency, ~9%), whereas it is considered a rare condition in most populations (prevalence of the severe deficiency, 1 in 106 in the white population). So far, >190 causative mutations have been identified throughout the F11 gene. To have a global landscape of genetic variation of F11, we explored publicly available exome-based data obtained from >60 000 individuals belonging to different ethnicities (Exome Aggregation Consortium resource). This analysis revealed profound differences in heterozygote frequencies among populations (allele frequencies: African 5 0.0016; East Asian 5 0.0045; European 5 0.0036; Finnish 5 0.00030; Latino 5 0.0021; South Asian 5 0.0015), and a prevalence significantly higher than that reported so far (eg, the calculated prevalence of the severe deficiency in Europeans would be: 12.9 in 106). In addition, this analysis allowed us to evidence recurrent and ethnic-specific mutations: p.Phe223Leu in Africans (23.5% of all mutated alleles), p.Gln263X and p.Leu424CysfsX in East Asians (28.2% and 20.5%, respectively), and p.Ala412Thr in Latinos (25%).

Original languageEnglish
Pages (from-to)e1-e6
JournalBlood
Volume130
Issue number4
DOIs
Publication statusPublished - Jul 27 2017

Fingerprint

Factor XI Deficiency
Factor XI
Exome
Heterozygote
Hispanic Americans
Population
Jews
Mutation
Agglomeration
Genes
Plasmas
Gene Frequency
Alleles
Hemorrhage

ASJC Scopus subject areas

  • Immunology
  • Biochemistry
  • Hematology
  • Cell Biology

Cite this

Exploring the global landscape of genetic variation in coagulation factor XI deficiency. / Asselta, Rosanna; Paraboschi, Elvezia Maria; Rimoldi, Valeria; Menegatti, Marzia; Peyvandi, Flora; Salomon, Ophira; Duga, Stefano.

In: Blood, Vol. 130, No. 4, 27.07.2017, p. e1-e6.

Research output: Contribution to journalArticle

@article{c67fae1c20a144bf858a11b141376088,
title = "Exploring the global landscape of genetic variation in coagulation factor XI deficiency",
abstract = "Factor XI (FXI) deficiency is an autosomal bleeding disorder, usually posttrauma or postsurgery, characterized by reduced levels of coagulation FXI in plasma. The disease is highly prevalent in Ashkenazi Jews (heterozygote frequency, ~9{\%}), whereas it is considered a rare condition in most populations (prevalence of the severe deficiency, 1 in 106 in the white population). So far, >190 causative mutations have been identified throughout the F11 gene. To have a global landscape of genetic variation of F11, we explored publicly available exome-based data obtained from >60 000 individuals belonging to different ethnicities (Exome Aggregation Consortium resource). This analysis revealed profound differences in heterozygote frequencies among populations (allele frequencies: African 5 0.0016; East Asian 5 0.0045; European 5 0.0036; Finnish 5 0.00030; Latino 5 0.0021; South Asian 5 0.0015), and a prevalence significantly higher than that reported so far (eg, the calculated prevalence of the severe deficiency in Europeans would be: 12.9 in 106). In addition, this analysis allowed us to evidence recurrent and ethnic-specific mutations: p.Phe223Leu in Africans (23.5{\%} of all mutated alleles), p.Gln263X and p.Leu424CysfsX in East Asians (28.2{\%} and 20.5{\%}, respectively), and p.Ala412Thr in Latinos (25{\%}).",
author = "Rosanna Asselta and Paraboschi, {Elvezia Maria} and Valeria Rimoldi and Marzia Menegatti and Flora Peyvandi and Ophira Salomon and Stefano Duga",
year = "2017",
month = "7",
day = "27",
doi = "10.1182/blood-2017-04-780148",
language = "English",
volume = "130",
pages = "e1--e6",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4",

}

TY - JOUR

T1 - Exploring the global landscape of genetic variation in coagulation factor XI deficiency

AU - Asselta, Rosanna

AU - Paraboschi, Elvezia Maria

AU - Rimoldi, Valeria

AU - Menegatti, Marzia

AU - Peyvandi, Flora

AU - Salomon, Ophira

AU - Duga, Stefano

PY - 2017/7/27

Y1 - 2017/7/27

N2 - Factor XI (FXI) deficiency is an autosomal bleeding disorder, usually posttrauma or postsurgery, characterized by reduced levels of coagulation FXI in plasma. The disease is highly prevalent in Ashkenazi Jews (heterozygote frequency, ~9%), whereas it is considered a rare condition in most populations (prevalence of the severe deficiency, 1 in 106 in the white population). So far, >190 causative mutations have been identified throughout the F11 gene. To have a global landscape of genetic variation of F11, we explored publicly available exome-based data obtained from >60 000 individuals belonging to different ethnicities (Exome Aggregation Consortium resource). This analysis revealed profound differences in heterozygote frequencies among populations (allele frequencies: African 5 0.0016; East Asian 5 0.0045; European 5 0.0036; Finnish 5 0.00030; Latino 5 0.0021; South Asian 5 0.0015), and a prevalence significantly higher than that reported so far (eg, the calculated prevalence of the severe deficiency in Europeans would be: 12.9 in 106). In addition, this analysis allowed us to evidence recurrent and ethnic-specific mutations: p.Phe223Leu in Africans (23.5% of all mutated alleles), p.Gln263X and p.Leu424CysfsX in East Asians (28.2% and 20.5%, respectively), and p.Ala412Thr in Latinos (25%).

AB - Factor XI (FXI) deficiency is an autosomal bleeding disorder, usually posttrauma or postsurgery, characterized by reduced levels of coagulation FXI in plasma. The disease is highly prevalent in Ashkenazi Jews (heterozygote frequency, ~9%), whereas it is considered a rare condition in most populations (prevalence of the severe deficiency, 1 in 106 in the white population). So far, >190 causative mutations have been identified throughout the F11 gene. To have a global landscape of genetic variation of F11, we explored publicly available exome-based data obtained from >60 000 individuals belonging to different ethnicities (Exome Aggregation Consortium resource). This analysis revealed profound differences in heterozygote frequencies among populations (allele frequencies: African 5 0.0016; East Asian 5 0.0045; European 5 0.0036; Finnish 5 0.00030; Latino 5 0.0021; South Asian 5 0.0015), and a prevalence significantly higher than that reported so far (eg, the calculated prevalence of the severe deficiency in Europeans would be: 12.9 in 106). In addition, this analysis allowed us to evidence recurrent and ethnic-specific mutations: p.Phe223Leu in Africans (23.5% of all mutated alleles), p.Gln263X and p.Leu424CysfsX in East Asians (28.2% and 20.5%, respectively), and p.Ala412Thr in Latinos (25%).

UR - http://www.scopus.com/inward/record.url?scp=85026288467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026288467&partnerID=8YFLogxK

U2 - 10.1182/blood-2017-04-780148

DO - 10.1182/blood-2017-04-780148

M3 - Article

C2 - 28615222

AN - SCOPUS:85026288467

VL - 130

SP - e1-e6

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4

ER -